91 related articles for article (PubMed ID: 16027846)
1. Prooxidant-antioxidant balance in the prostate and blood of rats with sulpyride[corrected]-induced prostatic hyperplasia corrected with prostatilen.
Belostotskaya LI; Gomon ON; Nikitchenko YV; Chaika LA; Bondar VV; Dzyuba VN
Bull Exp Biol Med; 2005 Mar; 139(3):334-6. PubMed ID: 16027846
[TBL] [Abstract][Full Text] [Related]
2. [Effect of biologically active substances of animal and plant origin on prooxidant-antioxidant balance in rats with experimental prostatic hyperplasia].
Belostotskaia LI; Nikitchenko IuV; Gomon ON; Chaĭka LA; Bondar' VV; Dziuba VN
Eksp Klin Farmakol; 2006; 69(4):66-8. PubMed ID: 16995443
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant enzyme activities and lipid peroxides in the plasma of patients with benign prostatic hyperplasia or prostate cancer are not predictive.
Doğru-Abbasoğlu S; Aykaç-Toker G; Koçak T; Unlüer E; Uysal M
J Cancer Res Clin Oncol; 1999 Jul; 125(7):402-4. PubMed ID: 10394960
[TBL] [Abstract][Full Text] [Related]
4. Dihydroquercetin effects on the morphology and antioxidant/prooxidant balance of the prostate in rats with sulpiride-induced benign hyperplasia.
Borovskaya TG; Krivova NA; Zaeva OB; Fomina TI; Kamalova SI; Poluektova ME; Vychuzhanina AV; Shchemerova YA; Grigor'eva VA; Goldberg VE; Plotnikov MB
Bull Exp Biol Med; 2015 Feb; 158(4):513-6. PubMed ID: 25708337
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of 2-hydroxy-4-methoxy benzoic acid on testosterone induced benign prostatic hyperplasia in Wister rats.
Ali MI; Kondreddi HD; Veeresh B
Eur J Pharmacol; 2013 Jan; 698(1-3):397-403. PubMed ID: 23123055
[TBL] [Abstract][Full Text] [Related]
6. [Activity of enzymatic antioxidant system in the rat tissues under conditions of over- and restricted nutrition].
Nikitchenko IuV; Dziuba VM; Popovych AS; Bondar VV; Sheremet HO
Ukr Biokhim Zh (1999); 2009; 81(6):104-10. PubMed ID: 20387664
[TBL] [Abstract][Full Text] [Related]
7. Blood and tissue selenium concentrations and glutathione peroxidase activities in patients with prostate cancer and benign prostate hyperplasia.
Zachara BA; Szewczyk-Golec K; Tyloch J; Wolski Z; Szylberg T; Stepien S; Kwiatkowski S; Bloch-Boguslawska E; Wasowicz W
Neoplasma; 2005; 52(3):248-54. PubMed ID: 15875088
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of Ponciri Fructus on testosterone-induced benign prostatic hyperplasia in rats.
Jeon WY; Kim OS; Seo CS; Jin SE; Kim JA; Shin HK; Kim YU; Lee MY
BMC Complement Altern Med; 2017 Aug; 17(1):384. PubMed ID: 28774334
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia.
Aydin A; Arsova-Sarafinovska Z; Sayal A; Eken A; Erdem O; Erten K; Ozgök Y; Dimovski A
Clin Biochem; 2006 Feb; 39(2):176-9. PubMed ID: 16413012
[TBL] [Abstract][Full Text] [Related]
10. Glutathione peroxidase isolated from plasma reduces phospholipid hydroperoxides.
Yamamoto Y; Takahashi K
Arch Biochem Biophys; 1993 Sep; 305(2):541-5. PubMed ID: 8373192
[TBL] [Abstract][Full Text] [Related]
11. [Prostatilen effects on voiding disorders in patients with benign prostatic hyperplasia].
Al'-Shukri SKh; Gorbachev AG; Borovets SIu; Belousov VIa; Kuz'min IV
Urologiia; 2005; (5):25-6. PubMed ID: 16281835
[TBL] [Abstract][Full Text] [Related]
12. Activity and content of antioxidant enzymes in prostate tumors.
Kotrikadze N; Alibegashvili M; Zibzibadze M; Abashidze N; Chigogidze T; Managadze L; Artsivadze K
Exp Oncol; 2008 Sep; 30(3):244-7. PubMed ID: 18806750
[TBL] [Abstract][Full Text] [Related]
13. [Prostatilen treatment of prostatic adenoma].
Al'-Shukri SKh; Gorbachev AG; Borovets SIu; Belousov VIa; Kuz'min IV; Chushkin KA
Urologiia; 2006; (6):22, 25-6. PubMed ID: 17315707
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress in benign prostate hyperplasia.
Zabaiou N; Mabed D; Lobaccaro JM; Lahouel M
Andrologia; 2016 Feb; 48(1):69-73. PubMed ID: 25959539
[TBL] [Abstract][Full Text] [Related]
15. In vivo analysis of antioxidant and prooxidant properties of retinol acetate.
Pravkin SK; Yakusheva EN; Uzbekova DG
Bull Exp Biol Med; 2013 Dec; 156(2):220-3. PubMed ID: 24319753
[TBL] [Abstract][Full Text] [Related]
16. Sex differences in the glutathione peroxidase activity of various tissues of the rat.
Capel ID; Smallwood AE
Res Commun Chem Pathol Pharmacol; 1983 Jun; 40(3):367-78. PubMed ID: 6622815
[TBL] [Abstract][Full Text] [Related]
17. [Characteristics of amaranth oil effect on the antioxidant system of the liver and blood in mice with malignant lymphoma growth].
Ielisieieva OP; Kamins'kyĭ DV; Cherkas AP; Ambarova LI; Vyshemyrs'ka LD; Dzhura OR; Semen KhO; Makhotina OO
Ukr Biokhim Zh (1999); 2006; 78(1):117-23. PubMed ID: 17147274
[TBL] [Abstract][Full Text] [Related]
18. [Lipid peroxidation in the myocardium in experimental infarct].
Savov VM; Didenko VV; Dosmagambetova RS; Meerson FZ; Kagan VE
Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (5):30-3. PubMed ID: 4027287
[TBL] [Abstract][Full Text] [Related]
19. Glutathione peroxidase activity, lipid peroxides and selenium concentration in various rat organs.
Gromadzińska J; Skłodowska M; Wasowicz W
Biomed Biochim Acta; 1988; 47(1):19-24. PubMed ID: 3390165
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of the efficiency of prostatotropic agents of natural origin in experimental benign prostatic hyperplasia.
Borovskaya TG; Fomina TI; Ermolaeva LA; Vychuzhanina AV; Pakhomova AV; Poluektova ME; Shchemerova YA
Bull Exp Biol Med; 2013 May; 155(1):67-70. PubMed ID: 23667874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
